Md. Code Ann., Ins. § 15-1633.1
Restrictions relating to request for therapeutic interchange
Effective Jan 1, 2022Added as Insurance § 15-1633 by Acts 2008, c. 203, § 1, eff. Oct. 1, 2008; Acts 2008, c. 204, § 1, eff. Oct. 1, 2008. Renumbered as Insurance § 15-1633.1 by Acts 2021, c. 358, § 1, eff. Jan. 1, 2022.State of Maryland
- (1) the proposed therapeutic interchange is for medical reasons that benefit the beneficiary; or
- (2) the proposed therapeutic interchange will result in financial savings and benefits to the purchaser or the beneficiary.
A pharmacy benefits manager or its agent may not request a therapeutic interchange unless:
Added as Insurance § 15-1633 by Acts 2008, c. 203, § 1, eff. Oct. 1, 2008; Acts 2008, c. 204, § 1, eff. Oct. 1, 2008. Renumbered as Insurance § 15-1633.1 by Acts 2021, c. 358, § 1, eff. Jan. 1, 2022.